$PFE Pfizer Q2 Earnings

04 Aug 2026 10:48PFE
  • Adj. EPS $0.77, est. $0.68
  • Rev. $15.03B, est. $14.41B
  • Eliquis rev. $2.43B, est. $2.09B
  • Prevnar franchise rev. $1.34B, est. $1.38B
  • Now expects total net cost savings of $6.7B
  • Anticipated productivity enhancement savings of $2.5B
  • Announces expansion of productivity initiatives
  • Still sees FY adj. EPS $2.80 to $3.00
  • Sees FY rev. $60.5B to $62.5B, saw $59.5B to $62.5B
  • Raises midpoint of 2026 rev. guidance
  • Raises sales guidance on strong demand for older drugs
  • Shares gain 2.2% after second quarter results